227 related articles for article (PubMed ID: 10813377)
1. Troglitazone inhibits mitogenic signaling by insulin in vascular smooth muscle cells.
Goetze S; Kim S; Xi XP; Graf K; Yang DC; Fleck E; Meehan WP; Hsueh WA; Law RE
J Cardiovasc Pharmacol; 2000 May; 35(5):749-57. PubMed ID: 10813377
[TBL] [Abstract][Full Text] [Related]
2. PPAR gamma-ligands inhibit migration mediated by multiple chemoattractants in vascular smooth muscle cells.
Goetze S; Xi XP; Kawano H; Gotlibowski T; Fleck E; Hsueh WA; Law RE
J Cardiovasc Pharmacol; 1999 May; 33(5):798-806. PubMed ID: 10226869
[TBL] [Abstract][Full Text] [Related]
3. Peroxisome proliferator-activated receptor gamma ligands inhibit mitogenic induction of p21(Cip1) by modulating the protein kinase Cdelta pathway in vascular smooth muscle cells.
Wakino S; Kintscher U; Liu Z; Kim S; Yin F; Ohba M; Kuroki T; Schönthal AH; Hsueh WA; Law RE
J Biol Chem; 2001 Dec; 276(50):47650-7. PubMed ID: 11598137
[TBL] [Abstract][Full Text] [Related]
4. Leptin induces endothelial cell migration through Akt, which is inhibited by PPARgamma-ligands.
Goetze S; Bungenstock A; Czupalla C; Eilers F; Stawowy P; Kintscher U; Spencer-Hänsch C; Graf K; Nürnberg B; Law RE; Fleck E; Gräfe M
Hypertension; 2002 Nov; 40(5):748-54. PubMed ID: 12411472
[TBL] [Abstract][Full Text] [Related]
5. Peroxisome proliferator-activated receptor-gamma ligands inhibit nuclear but not cytosolic extracellular signal-regulated kinase/mitogen-activated protein kinase-regulated steps in vascular smooth muscle cell migration.
Goetze S; Kintscher U; Kim S; Meehan WP; Kaneshiro K; Collins AR; Fleck E; Hsueh WA; Law RE
J Cardiovasc Pharmacol; 2001 Dec; 38(6):909-21. PubMed ID: 11707695
[TBL] [Abstract][Full Text] [Related]
6. Troglitazone and rosiglitazone induce apoptosis of vascular smooth muscle cells through an extracellular signal-regulated kinase-independent pathway.
Gouni-Berthold I; Berthold HK; Weber AA; Ko Y; Seul C; Vetter H; Sachinidis A
Naunyn Schmiedebergs Arch Pharmacol; 2001 Feb; 363(2):215-21. PubMed ID: 11218074
[TBL] [Abstract][Full Text] [Related]
7. Troglitazone and rosiglitazone inhibit the low density lipoprotein-induced vascular smooth muscle cell growth.
Gouni-Berthold I; Berthold HK; Weber AA; Seul C; Vetter H; Sachinidis A
Exp Clin Endocrinol Diabetes; 2001; 109(4):203-9. PubMed ID: 11453032
[TBL] [Abstract][Full Text] [Related]
8. 15-Deoxy-delta 12,14-prostaglandin J2 and thiazolidinediones activate the MEK/ERK pathway through phosphatidylinositol 3-kinase in vascular smooth muscle cells.
Takeda K; Ichiki T; Tokunou T; Iino N; Takeshita A
J Biol Chem; 2001 Dec; 276(52):48950-5. PubMed ID: 11687581
[TBL] [Abstract][Full Text] [Related]
9. Troglitazone inhibits growth and improves insulin signaling by suppression of angiotensin II action in vascular smooth muscle cells from spontaneously hypertensive rats.
Fukuda N; Hu WY; Teng J; Chikara S; Nakayama M; Kishioka H; Kanmatsuse K
Atherosclerosis; 2002 Aug; 163(2):229-39. PubMed ID: 12052469
[TBL] [Abstract][Full Text] [Related]
10. Peroxisome proliferator-activated receptor gamma activators inhibit gene expression and migration in human vascular smooth muscle cells.
Marx N; Schönbeck U; Lazar MA; Libby P; Plutzky J
Circ Res; 1998 Nov; 83(11):1097-103. PubMed ID: 9831704
[TBL] [Abstract][Full Text] [Related]
11. Troglitazone inhibits angiotensin II-induced DNA synthesis and migration in vascular smooth muscle cells.
Graf K; Xi XP; Hsueh WA; Law RE
FEBS Lett; 1997 Jan; 400(1):119-21. PubMed ID: 9000525
[TBL] [Abstract][Full Text] [Related]
12. Effects of troglitazone on cellular differentiation, insulin signaling, and glucose metabolism in cultured human skeletal muscle cells.
Kausch C; Krützfeldt J; Witke A; Rettig A; Bachmann O; Rett K; Matthaei S; Machicao F; Häring HU; Stumvoll M
Biochem Biophys Res Commun; 2001 Jan; 280(3):664-74. PubMed ID: 11162573
[TBL] [Abstract][Full Text] [Related]
13. Peroxisome proliferator-activated receptor (PPAR)-gamma expression in human vascular smooth muscle cells: inhibition of growth, migration, and c-fos expression by the peroxisome proliferator-activated receptor (PPAR)-gamma activator troglitazone.
Benson S; Wu J; Padmanabhan S; Kurtz TW; Pershadsingh HA
Am J Hypertens; 2000 Jan; 13(1 Pt 1):74-82. PubMed ID: 10678274
[TBL] [Abstract][Full Text] [Related]
14. Peroxisome proliferator-activated receptor gamma ligands inhibit retinoblastoma phosphorylation and G1--> S transition in vascular smooth muscle cells.
Wakino S; Kintscher U; Kim S; Yin F; Hsueh WA; Law RE
J Biol Chem; 2000 Jul; 275(29):22435-41. PubMed ID: 10801895
[TBL] [Abstract][Full Text] [Related]
15. Troglitazone inhibits alpha1-adrenoceptor-induced DNA synthesis in vascular smooth muscle cells.
Nishio E; Watanabe Y
Eur J Pharmacol; 1999 Jun; 374(1):127-35. PubMed ID: 10422649
[TBL] [Abstract][Full Text] [Related]
16. Regulation of the growth arrest and DNA damage-inducible gene 45 (GADD45) by peroxisome proliferator-activated receptor gamma in vascular smooth muscle cells.
Bruemmer D; Yin F; Liu J; Berger JP; Sakai T; Blaschke F; Fleck E; Van Herle AJ; Forman BM; Law RE
Circ Res; 2003 Aug; 93(4):e38-47. PubMed ID: 12881480
[TBL] [Abstract][Full Text] [Related]
17. Thiazolidinediones, peroxisome proliferator-activated receptor gamma agonists, regulate endothelial cell growth and secretion of vasoactive peptides.
Fukunaga Y; Itoh H; Doi K; Tanaka T; Yamashita J; Chun TH; Inoue M; Masatsugu K; Sawada N; Saito T; Hosoda K; Kook H; Ueda M; Nakao K
Atherosclerosis; 2001 Sep; 158(1):113-9. PubMed ID: 11500181
[TBL] [Abstract][Full Text] [Related]
18. Critical role of c-Jun N-terminal protein kinase activation in troglitazone-induced apoptosis of human HepG2 hepatoma cells.
Bae MA; Song BJ
Mol Pharmacol; 2003 Feb; 63(2):401-8. PubMed ID: 12527812
[TBL] [Abstract][Full Text] [Related]
19. PPAR activators inhibit endothelial cell migration by targeting Akt.
Goetze S; Eilers F; Bungenstock A; Kintscher U; Stawowy P; Blaschke F; Graf K; Law RE; Fleck E; Gräfe M
Biochem Biophys Res Commun; 2002 May; 293(5):1431-7. PubMed ID: 12054675
[TBL] [Abstract][Full Text] [Related]
20. Dual function of troglitazone in ICAM-1 gene expression in human vascular endothelium.
Chen NG; Han X
Biochem Biophys Res Commun; 2001 Apr; 282(3):717-22. PubMed ID: 11401521
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
